Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Role of the sorting receptor SorCS1 in controlling excitation/inhibition balance in neural circuits.

SorCSbalance

Controlling the precise balance between excitation and inhibition (E/I balance) is critical for information processing in the brain. A perturbed E/I balance has been implicated in the etiology of a wide range of neuropsychiatric disorders. The factors that dictate the balance between excitatory and inhibitory synaptic transmission are still poorly...

Funding Programme
Start Date
End Date
Total Funding
€ 160 800
European Countries Involved

Roles of astrocytes in synaptic transmission and plasticity

ASTROSYN

The research area of this proposal is Life Science at the intersection of neuroscience, pharmacology and physiology. In the central nervous system (CNS), astrocytes are both numerous and complex. They contact most other cell types in the CNS, and the processes of a single astrocyte can envelop as many as 140,000 synapses. Thus, these cells are...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

Rosetta Guidance and Awareness Services for Independent Living

ROSETTA

The objective of ROSETTA is to help community dwelling people with progressive chronic disabilities, such as Alzheimer’s Disease, to retain their autonomy and quality of life as much as possible and to support their (in)formal carers by developing and providing an ICT system that offers activity guidance and awareness services for independent...

Funding Programme
Start Date
End Date
Total Funding
€ 3 273 350
European Countries Involved

Safeguarding Cell Identities: Mechanisms Counteracting Cell Fate Reprogramming

REPROWORM

Regenerating tissues by reprogramming cells has the potential to become a therapeutic approach for replacing lost tissues in patients suffering from injury or degenerative diseases such as Alzheimer’s or Muscular Dystrophy. Strategies to generate required tissues using embryonic stem cells or induced pluripotent stem cells (iPSCs) are associated...

Funding Programme
Start Date
End Date
Total Funding
€ 1 457 938
European Countries Involved

SAfety of elderly people and Vicinity Ensuring 

SAVE

“SAVE” is dedicated to the elderly persons, suffering (or at risk of) age-related chronic illnesses and/or mild cognitive issues/disabilities. For these, and a range of “not-so-fit” persons, “SAVE” aims to avoid psychosocial exclusion by “restoring the referential”. The unique goal of “orientation” in a supportive environment – in terms of position...

Funding Programme
Start Date
End Date
Total Funding
€ 1 155 137
European Countries Involved

Self-management and HeAlth Promotion in Early-stage dementia with e-learning for carers – A randomised controlled trial

SHAPE

We will develop and validate an intervention (SHAPE) in 330 people with mild dementia; combining self-management, health promotion, and e-learning. The study is a multi-site, randomised, controlled, single-blinded trial with parallel groups. The intervention group is compared with treatment as usual (TAU). The primary outcome is to evaluate the...

Funding Programme
Start Date
End Date
Total Funding
€ 2 887 000
European Countries Involved

Self-management interventions and mutual assistance community services, helping patients with dementia and caregivers connect with others for evaluation, support and inspiration to improve the care experience

CAREGIVERSPRO-MMD

According to the World Health Organisation (WHO, ADI), 44 million people around the world have some form of dementia, for which there is no effective intervention, to halt or reverse the progressive cognitive impairment. As Europe’s population is ageing, long-term care for elderly citizens will become an increasing cost for society. To manage this...

Funding Programme
Start Date
End Date
Total Funding
€ 4 087 199
European Countries Involved

Sensor Enabled Affective Computing for Enhancing Medical Care

SenseCare

This project brings together a diverse group of subject matter experts from industry and academia under one umbrella, with the main aim of enhancing and advancing future healthcare processes and systems using sensory and machine learning technologies to provide emotional (affective) and cognitive insights into patients well-being so as to provide...

Funding Programme
Start Date
End Date
Total Funding
€ 504 000
European Countries Involved

SERS –tweezers enhanced by electro-thermo-plasmonic flow

SERSET

Direct quantification of dopamine neurotransmission is one of the unsolved problems that engaged scientific minds for the last fifty years. Such quantification is an extremely important tool to understand the underlying pathways that promote neurodegenerative diseases like Alzheimer's and depression. Since dopamine is secreted only in micro-molar...

Funding Programme
Start Date
End Date
Total Funding
€ 165 312
European Countries Involved

Significance of TDP-43 in the population in relation to dementia

STPRD

The incidence and prevalence of dementia is rising as the world-wide population ages. Determining biomarkers for the early detection of underlying biology that will predict dementia progression reliably or, the monitoring of biological processes once present to track progression and treatment is necessary. Furthermore, these biomarkers will aid in...

Funding Programme
Start Date
End Date
Total Funding
€ 182 485
European Countries Involved

Simulation of the Kinetics and Inverse Problem
for the Protein PolymERization
in Amyloid Diseases (Prion, Alzheimer’s)

SKIPPERAD

Amyloid diseases are of increasing concern in our aging society. These diseases all involve the aggregation of misfolded proteins, called amyloid, which are specific for each disease (PrP for Prion, Abeta for Alzheimer's). When misfolded these proteins propagate the abnormal configuration and aggregate to others, forming very long polymers also...

Funding Programme
Start Date
End Date
Total Funding
€ 1 203 569
European Countries Involved

Single-molecule imaging with SPAD array detection

SM-SPAD

The resolution limit of about 250 nm in conventional optical microscopes is problematic in the study of structural biology, since proteins, macromolecules and nuclear acids are typically much smaller than 100 nm. Single-molecule localization microscopy is able to circumvent this limit by sequentially and stochastically switching on/activating...

Funding Programme
Start Date
End Date
Total Funding
€ 171 473
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).